Editorials The Pharmaceutical Price Regulation Scheme BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39136.464421.BE (Published 01 March 2007) Cite this as: BMJ 2007;334:435 Article Related content Metrics Responses Peer review Related articles Analysis Value based pricing for NHS drugs: an opportunity not to be missed? Published: 31 January 2008; BMJ 336 doi:10.1136/bmj.39434.500185.25 See more Gordon McVie: medical oncologist who helped drive the formation of Cancer Research UK BMJ February 26, 2021, 372 n570; DOI: https://doi.org/10.1136/bmj.n570 Jeremy Farrar: Make vaccine available to other countries as soon as our most vulnerable people have received it BMJ February 26, 2021, 372 n581; DOI: https://doi.org/10.1136/bmj.n581 Covid-19: NHS England pledges extra funding to local areas to reduce vaccine inequalities BMJ February 26, 2021, 372 n580; DOI: https://doi.org/10.1136/bmj.n580 Covid-19: Young mother should be allowed to die in “almost unbearable” tragedy, says judge BMJ February 26, 2021, 372 n577; DOI: https://doi.org/10.1136/bmj.n577 Covid-19: Outcomes worsened in second wave for Pakistanis and Bangladeshis in England BMJ February 26, 2021, 372 n572; DOI: https://doi.org/10.1136/bmj.n572 Cited by... Value based pricing for NHS drugs: an opportunity not to be missed?Fulltext PDF
